Insurance Capital Accelerates Towards 'Hard Tech', China Life Insurance Commits 5 Billion to Semiconductor Supply Chain

Deep News07-10

China Life Insurance has made another strategic move into emerging industries.

On July 10th, China Life Insurance Company Limited announced its intention to invest 4.999 billion yuan alongside its affiliate, China Life Industry Investment Management Co., Ltd., to establish the Tianjin Shenghe Xincheng Equity Investment Fund Partnership. The total committed capital from all partners of this fund is 5 billion yuan, with a duration of 8 years, and it will focus on investing in companies within the semiconductor industry.

This follows a previous major investment in the semiconductor supply chain by the China Life system in November 2023, when China Life Asset Management initiated the "China Life - Hufa No. 1 Equity Investment Plan" (with an investment scale of approximately 11.8 billion yuan at the time). The latest initiative takes the form of an industrial fund, with its investments explicitly targeted at companies providing process support services for semiconductor design firms and other system companies. Against the backdrop of continuously expanding AI computing power demand and the accelerated efforts to strengthen domestic semiconductor supply chains, this announcement from China Life carries significant signaling importance.

China Life System Fully Funds the 5 Billion Yuan Fund

According to the announcement, China Life Insurance Company Limited intends to contribute 4.999 billion yuan as a limited partner, while China Life Industry will contribute 1 million yuan as a general partner, jointly establishing the Tianjin Shenghe Xincheng Equity Investment Fund Partnership with a total scale of 5 billion yuan.

The fund's term structure is fairly typical: an operational period of 8 years, comprising a 2-year investment phase followed by a 6-year exit phase. If operational needs require, the term can be extended twice, for one year each time, subject to unanimous consent from all partners. This means the fund could operate for up to 10 years.

In terms of capital structure, China Life is the overwhelmingly dominant contributor, with a commitment ratio approaching 100%. China Life Industry, as the general partner and executive affairs partner, is responsible for the fund's execution and investment operations; China Life Capital, as the fund manager, provides daily operational and investment management services. These three entities within the China Life system have taken on the entire funding, management, and operational roles.

Profit Distribution Model is Also 'Standard'

Regarding specific returns and fee structures, the announcement shows that for management fees, the fund will pay the manager an annual fee calculated as 0.2% of the investment principal from the limited partner's paid-in capital, with no fees charged during any extension period. Compared to the typical management fee levels seen in market-oriented private equity funds, this rate is not high, reflecting the long-term cooperative nature within the group.

For profit distribution, the fund adopts a model of "first return capital, then pay hurdle returns, finally share excess profits": First, distribute to all partners (i.e., China Life and China Life Industry) until their paid-in capital is recovered; subsequently, distribute to the limited partner (i.e., China Life) until it achieves an annualized internal rate of return of 8%; then distribute to the general partner (i.e., China Life Industry) until it achieves an annualized internal rate of return of 8%; any remaining profits are then distributed with the limited partner receiving 80% and the general partner receiving 20%.

Investment Targets Are Clearly Defined

The announcement also clearly states that this partnership will focus its investments on semiconductor industry companies. It is currently anticipated that the raised funds will be invested in "equity of target companies that provide process support services for design companies and other system companies," with an ownership stake not exceeding 3%.

The announcement further describes the intended target investment enterprises as possessing "profound technological沉淀 and resource accumulation within the semiconductor industry, with outstanding core technological advantages and a完备的 R&D system." As a significant force of state-owned capital, China Life's participation in investing in the strategic emerging semiconductor industry through this transaction is both a fulfillment of its responsibility to provide financial services in support of national strategy and a concrete manifestation of its role as long-term, patient capital.

Some industry analysis suggests that so-called "target companies providing process support services for design companies and other system companies" often refer to foundry enterprises that provide manufacturing for semiconductor design companies, representing a core细分 industry within the current AI semiconductor supply chain.

China Life's participation in investing in such enterprises represents support for consolidating domestic computing power infrastructure and strengthening the semiconductor hardware manufacturing behind computing capabilities.

Insurance Capital Entering 'Hard Tech' is Becoming a Trend

In the past, insurance capital investments showed a preference for assets like fixed income, real estate, and infrastructure. However, in recent years, with the downward trend in interest rates and pressure on returns from traditional assets, insurance capital has been seeking new sources of long-term returns.

While hard tech fields such as semiconductors, artificial intelligence, and high-end manufacturing experience significant short-term industry volatility, they offer vast medium-to-long-term growth potential and align with the direction of national industrial upgrading. These areas are gradually emerging as new focal points for insurance capital investment.

From a functional perspective, the continued "advance" of insurance capital into investing in strategic emerging industries offers at least the following benefits:

First, it supports the need for diversified, long-term asset allocation by insurance funds. Insurance capital must find a balance between safety, yield, and liquidity in the future, and equity investments in high-quality technology companies can provide potential超额 returns for long-term capital.

Second, it also represents insurance capital serving national strategy. The semiconductor supply chain is the core infrastructure for the AI industry and the digital economy, as well as a crucial link in ensuring supply chain security and健全完善 the industrial system. Large state-owned financial institutions like China Life participating in investments through industrial funds helps enhance the supply of financial capital in this领域.

Third, it aligns with the strategic need for large insurance capital to continuously build industrial investment capabilities. Experience in primary market and real economy investments is of great significance for future insurance capital management. Insurance companies like China Life, which are building investment capabilities covering multiple directions—such as infrastructure, elderly care, AI, semiconductors, and technology innovation through various forms—are more likely to gain a competitive edge in future industry competition and market dynamics.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment